Suppr超能文献

新诊断1型糖尿病患者及其一级亲属中的胰岛抗原-2抗体和抗谷氨酸脱羧酶抗体

[IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].

作者信息

Kretowski A, Kowalska I, Peczyńska J, Urban M, Kinalska I

机构信息

Klinika Endokrynologii Akademia Medyczna w Białymstoku.

出版信息

Przegl Lek. 2000;57(3):143-6.

Abstract

Antibodies recognising different pancreatic autoantigens (Abs) are detected many years before the clinical onset of insulin-dependent diabetes mellitus (IDDM). The humoral immune alterations, observed in the susceptible subjects, for example in first degree relatives of IDDM patients, could serve as predictive markers of IDDM development. It has recently been suggested that the predictive value of these humoral markers is associated with the number of the studied antibodies directed against different pancreatic antigens (ICA, GADA, IA-2,A IAA). The aim of the study was the estimation of the prevalence and titre of the antibodies directed against protein tyrosine phosphatase-2 (IA-2) and glutamic acid decarboxylase (GAD) in patients with newly diagnosed diabetes type 1 and their first degree relatives. The investigations were carried out in 52 diabetics (aged 5-25 years) and 136 first degree relatives. IA-2A and GADA were performed by radiobinding assay (RIA) using 2 microliters of serum and recombinant S35-labelled GAD65 and IA-2 antigens. The threshold of Abs detection was > or = 97.5 centile (of healthy schoolchildren). At least one of the antibody marker was detected in 92.7% of newly diagnosed IDDM patients, slightly more frequently observed were GADA (78.8%) than IA-2A (71.2%). The presence of 2 types of antibodies was found in 8.7% of parents and 9.4% of the siblings. The results of our study confirm high sensitivity and specificity of the combined measurement of IA-2A and GADA in recognising of autoimmune alterations in diabetes type 1 development. Taking into consideration small volume of the serum suitable for Abs measurement and possibility of the combined estimation of these Abs it seems that IA-2A and GADA combined measurement could actually serve as a screening marker for the detection of high risk of IDDM subjects also in the Polish population, but studies concerning their predictive value in the general population are suggested.

摘要

在胰岛素依赖型糖尿病(IDDM)临床发病前许多年就能检测到识别不同胰腺自身抗原的抗体(Abs)。在易感人群中观察到的体液免疫改变,例如IDDM患者的一级亲属,可作为IDDM发病的预测指标。最近有人提出,这些体液标志物的预测价值与针对不同胰腺抗原(ICA、GADA、IA - 2、IAA)的研究抗体数量有关。本研究的目的是评估新诊断的1型糖尿病患者及其一级亲属中针对蛋白酪氨酸磷酸酶 - 2(IA - 2)和谷氨酸脱羧酶(GAD)的抗体的患病率和滴度。对52名糖尿病患者(年龄5 - 25岁)和136名一级亲属进行了调查。使用2微升血清以及重组S35标记的GAD65和IA - 2抗原,通过放射结合测定(RIA)检测IA - 2A和GADA。抗体检测阈值为>或 = 健康学童的第97.5百分位数。在新诊断的IDDM患者中,92.7%检测到至少一种抗体标志物,其中GADA(78.8%)的检出频率略高于IA - 2A(71.2%)。在8.7%的父母和9.4%的兄弟姐妹中发现存在两种抗体。我们的研究结果证实了IA - 2A和GADA联合检测在识别1型糖尿病发病中的自身免疫改变方面具有高敏感性和特异性。考虑到适用于抗体检测的血清量少以及联合检测这些抗体的可能性,IA - 2A和GADA联合检测实际上似乎可作为波兰人群中检测IDDM高危个体的筛查标志物,但建议开展关于它们在一般人群中预测价值的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验